>

Richard Gonzalez - AbbVie Chairman, CEO and Chairman of Executive Committee

<div class='circular--portrait' style='background:#CD0D74;color: white;font-size:3em;padding-top: 40px;;'>ABB</div>
ABBV -- USA Stock  

Fiscal Quarter End: March 31, 2020  

  Chairman
Mr. Richard A. Gonzalez is the Chairman of the Board, Chief Executive Officer of the Company. Mr. Gonzalez is the chairman and chief executive officer of AbbVie. He served as Abbott executive vice president of the pharmaceutical products group from July 2010 to December 2012, and was responsible for Abbott worldwide pharmaceutical business, including commercial operations, research and development, and manufacturing. He also served as president, Abbott Ventures Inc., Abbott medical technology investment arm, from 2009 to 2011. Mr. Gonzalez joined Abbott in 1977 and held various management positions before briefly retiring in 2007, including Abbott president and chief operating officer president, chief operating officer of Abbott Medical Products Group senior vice president and president of Abbott former Hospital Products Division vice president and president of Abbott Health Systems Division and divisional vice president and general manager for Abbott Diagnostics Operations in the United States and Canada. As a result of his service as Abbott executive vice president, Pharmaceutical Products Group, his previous service as Abbott president and chief operating officer and his more than 30year career at Abbott, Mr. Gonzalez has developed valuable business, management and leadership experience, as well as extensive knowledge of AbbVie and its global operations. Mr. Gonzalez experience and knowledge enable him to contribute to AbbVie board key insights into strategic, management, and operational matters.
Age: 64  Chairman Since 2013      
847 932-7900  www.abbvie.com
Gonzalez joined Abbott in 1977 and held various management positions before briefly retiring in 2007, including: Abbott president and chief operating officer; president, chief operating officer of Abbott Medical Products Group; senior vice president and president of Abbott former Hospital Products Division; vice president and president of Abbott Health Systems Division; and divisional vice president and general manager for Abbott Diagnostics Operations in the United States and Canada.

Richard Gonzalez Latest Insider Activity

Management Efficiency

The company currently holds 38.84 B in liabilities with Debt to Equity (D/E) ratio of 9.53 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AbbVie has Current Ratio of 1.13 suggesting that it is in a questionable position to pay out its financial obligations when they are due.

Similar Executives

Showing few of many executives

CHAIRMAN Since

Alex KrauerNovartis AG
N/A
Moncef SlaouiGlaxoSmithKline PLC
2014
Leif JohanssonAstrazeneca PLC
2012
Jorge MesquitaJohnson Johnson
2016
Lamberto AndreottiBristol Myers Squibb Company
2015
Alex GorskyJohnson Johnson
2012
Jennifer TaubertJohnson Johnson
2018
Enrico VanniNovartis AG
2013
John MartinGilead Sciences
N/A
Brenton SaundersAllergan Plc
2016
Sandra PetersonJohnson Johnson
2017
Paulus StoffelsJohnson Johnson
2018
Ulrich LehnerNovartis AG
2006
Daniel VasellaNovartis AG
N/A
Joerg ReinhardtNovartis AG
2013
Paul BisaroAllergan Plc
2016
Ian ReadPfizer
2018
Kenneth FrazierMerck Company
2011
Joaquin DuatoJohnson Johnson
2018
John LechleiterEli Lilly And Company
2016
Ashley McEvoyJohnson Johnson
2018

Company Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. AbbVie operates under Drug Manufacturers - General classification in USA and is traded on BATS Exchange.AbbVie (ABBV) is traded on BATS Exchange in USA. It is located in 1 North Waukegan Road, North Chicago, IL 60064-6400, United States and employs 30,000 people. AbbVie is listed under Pharmaceutical Products category by Fama And French industry classification.

AbbVie Leadership Team

Richard Gonzalez, Chairman, CEO and Chairman of Executive CommitteeView
Brian Durkin, Vice President ControllerView
Thomas Hurwich, Vice President ControllerView
Frederick Waddell, Independent DirectorView
Robert Alpern, Independent DirectorView
Glenn Tilton, Independent DirectorView
Carlos Alban, Executive VP of Commercial OperationsView
Robert Michael, Vice President ControllerView
Henry Gosebruch, Executive Vice President Chief Strategy OfficerView
Jeffrey Stewart, Senior Vice President U.S. Commercial OperationsView
Rebecca Roberts, Independent DirectorView
Edward Liddy, Independent DirectorView
Brett Hart, Independent DirectorView
William Chase, CFO and Executive VPView
William Burnside, Independent DirectorView
Roxanne Austin, Independent DirectorView
Timothy Richmond, Sr. VP of HRView
Nicholas Donoghoe, Senior Vice President - Enterprise InnovationView
Laura Schumacher, Executive VP of Bus. Devel. and External Affairs, General Counsel and Corporate SecretaryView
Roy Roberts, Independent DirectorView
Michael Severino, Executive Vice President - Research & Development, Chief Scientific OfficerView
Azita SalekiGerhardt, Senior Vice President - OperationsView
Edward Rapp, Independent DirectorView
Melody Meyer, DirectorView

Stock Performance Indicators

Did you try this?

Run Instant Ratings Now

   

Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

AbbVie Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for AbbVie and Johnson Johnson. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Please continue to Trending Equities. Please also try Price Ceiling Movement module to calculate and plot price ceiling movement for different equity instruments.